血细胞疾病中的克隆性造血突变:临床子组和共享致病性
Xuezhu Wang1, Liping Zuo2, Yanying Yu1
1Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Genomics, proteomics & bioinformatics
|March 28, 2025
概括
诸如多发性骨髓瘤和粉样化等血细胞疾病中的克隆性造血突变会影响疾病的进展和患者的结果. 这些遗传变化提供了对共同疾病途径的见解,并有助于识别不同的患者子组.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 血细胞疾病 (PCD) 涉及异常的血细胞增殖,导致并发症.
- 多发性骨髓瘤 (MM) 和意义不明的单克隆性胃病变 (MGUS) 是常见的,而初级轻链性粉样化症 (AL) 和POEMS综合征 (POEMS) 是罕见的和不太了解的.
- 了解克隆性造血 (CH) 突变对于阐明PCD病原性至关重要.
研究的目的:
- 调查CH突变及其在PCD中的相互联系的作用.
- 为了确定驱动疾病进展和影响临床特征的特定突变.
- 探索不同PCD亚型的共同遗传基础.
主要方法:
- 从MM,AL和POEMS患者的骨髓血细胞 (BMPC) 中测序CH和髓瘤驱动基因突变.
- 对克隆和亚克隆血细胞群中的突变负担和分布的分析.
- 二元矩阵因子化以确定与突变相关的子组和临床特征.
主要成果:
- 发现了复发性淋巴细胞CH突变 (FAT1,KMT2D,MGA,SYNE1) 和骨髓瘤驱动突变 (ZFHX3,DIS3).
- 淋巴细胞CH突变在MM中比AL或POEMS更为普遍,并且与衰老有关.
- 突变模式揭示了与无进展生存 (PFS),年龄,自由光链水平,血细胞负担和VEGF水平相关的子组.
- 在MM,AL和POEMS中,MGA或SYNE1突变始终与糟糕的PFS相关.
结论:
- CH突变部分解释了MM,AL,POEMS和MGUS的共同致病性.
- 特定突变可以识别具有明显临床特征和预后的患者子组.
- 这项研究提高了对PCD的理解,并有助于个性化治疗策略.
相关概念视频
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:21Lineage Commitment
Commitment is the process whereby stem cells:
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...